Introduction
The major risk factor for esophageal adenocarcinoma (EA) is gastroesophageal reflux disease (GERD) complicated by Barrett's esophagus (BE) (Lagergren et al., 1999; Kahrilas, 2011; Pohl et al., 2013) . The mechanisms of the progression from BE to EA are not fully understood. Acid reflux is thought to contribute to this progression (Fitzgerald et al., 1996; El-Serag et al., 2004; Zhang et al., 2009; Das et al., 2011; Kastelein et al., 2013) . NOX5-S has been shown by us to mediate acid induced-increase in H 2 O 2 production and cell proliferation in EA cells (Fu et al., 2006; Si et al., 2007) since acid exposure-induced increase in H 2 O 2 production and cell proliferation is blocked by knockdown of NOX5-S. The mechanisms of NOX5-S-dependent increase in cell proliferation and decrease in apoptosis are not fully understood. We have shown that COX2 upregulation (Si et al., 2007) and p16 downregulation (Hong et al., 2010b ) may partially mediate NOX5-S-dependent increase in cell proliferation.
Besides COX2 and p16, other proteins may also be involved in NOX5-S-dependent increase in cell proliferation and decrease in apoptosis. SODD was identified in 1999 and belongs to a family of anti-apoptotic proteins of the BAG family (Takayama et al., 1999) . SODD contains a conserved region of approximately 45 amino acids near its C terminal end, the so-called BAG domain. A potential role of SODD in carcinogenesis has been proposed based on increased mRNA levels in cancer tissues; e.g. pancreatic cancers (Ozawa et al., 2000) . The over-expression of SODD in various cancer cell lines is reported to suppress cell death (Jiang et al., 1999; Ozawa This article has not been copyedited and formatted. The final version may differ from this version. JPET Fast Forward. Published on October 18, 2016 as DOI: 10.1124 at ASPET Journals on October 31, 2016 jpet.aspetjournals.org Downloaded from JPET #236620 5 et al., 2000) . We now show that acid increased SODD gene expression, which inhibited cell apoptosis in EA FLO cells. Acid-induced SODD expression may depend on activation of NOX5-S and NF-κB1 p50 in these cells.
Material and Methods
Cell culture and acid treatment-Cell culture and acid treatment were similar to those we described previously (Hong et al., 2010a; Hong et al., 2013; Hong et al., 2016) (Hughes et al., 1997) (University of Michigan Medical School). FLO cells were cultured in DMEM containing 10% fetal bovine serum and antibiotics. All the cell lines were cultured at 37 °C in a 5 % CO 2 humidified atmosphere.
This article has not been copyedited and formatted. The final version may differ from this version. for an additional 24 hours. Finally, the culture medium and cells were collected for measurements. Acidic DMEM (pH 4.0, 300μl) was added to each well in a 12-well plate, and the final pH was about 4.9 after a 1-h incubation. CP-A cells were exposed to acidic culture medium (pH 6.5) or normal culture medium (pH 7.2, control) for 24 hours and then collected for measurements. Small interfering RNA (siRNA) and plasmid transfection-The transfection protocol has been described previously by us (Hong et al., 2010a; Hong et al., 2013; Hong et al., 2016) .
Human esophageal tissues-
Briefly, transfection of siRNAs was achieved by using Lipofectamine 2000 (Invitrogen, Carlsbad, CA). 75 pmol of NOX5-S siRNA (Ambion Inc., Austin, TX), NF-κB p50 siRNA (Santa Cruz biotechnologies) or control siRNA formulated into liposomes were added to each well. 24 hours after transfection, cells were treated with acidic culture medium as described above.
The pCMV-tag5a-NOX5-S plasmid was obtained from Dr. or control plasmid by using Amaxa-Nucleofector-System (Lonza).
Reverse Transcription-PCR-RT-PCR was performed as we previously described (Hong et al., 2010a; Hong et al., 2013; Hong et al., 2016) . Total RNA was extracted by TRIzol reagent and 1.5 μ g of total RNA was reversely transcribed by using a kit SuperScript® First-Strand Synthesis System for RT-PCR (Invitrogen, Carlsbad, CA).
Quantitative Real Time PCR-Real time PCR was performed as we previously described (Hong et al., 2010a; Hong et al., 2013; Hong et al., 2016) and carried out on a StepOne™
Real-Time PCR System (Thermo Fisher Scientific Inc.). The primers used were: SODD F: 5'- Western Blot Analysis-Western blot analysis was done as described previously (Cao et al., 2003; Hong et al., 2010a; Hong et al., 2013; Hong et al., 2016) . Primary antibodies used were as follows: SODD antibody (1:1000, Santa Cruz biotechnologies) and GAPDH antibody (1:2000, Santa Cruz biotechnologies).
Luciferase Assay-Luciferase assay was done as we previously described (Fu et al., 2006; Hong et al., 2013 Variation in transfection efficiency was normalized by dividing the construct luciferase activity by the corresponding renilla luciferase activity.
Chromatin Immunoprecipitation (ChIP) Assay-ChIP assay was performed using the ChIP assay kit (Upstate, Charlottesville, VA) following manufacturer's protocol as we previously described (Fu et al., 2006; Hong et al., 2013) . PCR was carried with the primer pairs that targeted the -1147 to -1019 region of the human SODD promoter (sense 5'-CACTTCCTGTAACACGTGTGG-3'and antisense 5'-GAGCGCCTCAGGGCCGACATGG-3') at 94 °C for 5 min, 94 °C for 30 s, 62 °C for 30 s, and 72 °C for 30 s for 35 cycles followed by a 7-min extension at 72 °C.
Gel Mobility Shift Assay-Gel shift assay was performed using the gel shift assay kit (Licor, Nebraska USA) following the manufacturer's protocol as we previously described (Fu et al., 2006; Hong et al., 2013) . Briefly, human SODD promoter oligonucleotides (-310 to -300) This article has not been copyedited and formatted. The final version may differ from this version. 
ELISA apoptosis detection assay-The levels of apoptosis are measured by using
ApoStrand™ ELISA apoptosis detection kit (Biomol, Plymouth Meeting, PA). This assay is based on the sensitivity of DNA in apoptotic cells to formamide denaturation and the denatured DNA is detected with an antibody against single-stranded DNA (ssDNA). We have successfully used this assay in our published work (Fu et al., 2006) . JPET #236620 11 caspase 9 activity was measured.
Caspase-Glo
The Caspase-Glo ® 9 assay is a homogeneous luminescent assay that measures caspase-9 activity. The assay provides a luminogenic substrate selective for caspase-9 in a buffer system optimized for caspase activity. The addition of a single Caspase-Glo® 9 Reagent in an "add-mix-measure" format results in cell lysis, followed by caspase cleavage of the substrate, and generation of a "glow-type" luminescent signal. The signal generated is proportional to the amount of caspase-9 activity present.
Materials:
Other reagents were purchased from Sigma.
Statistical Analysis-Data is expressed as mean ± S.E. Statistical differences between two groups were determined by Student's t test. Differences among multiple groups were tested using analysis of variance (ANOVA) and checked for significance using Fisher's protected least significant difference test. For immunohistochemical data, statistical differences were determined by Chi square test.
Results

Expression of SODD in different esophageal tissues and cells
We found that SODD mRNA were significantly increased by 345.8% control in human EA To further confirm these data, we did immunohistochemical staining with SODD antibody.
We found that strong SODD immunostaining was significantly higher in low-grade dysplasia (66.7%), high-grade dysplasia (81.2%) and esophageal adenocarcinoma (71.2%) than in Barrett's mucosa (figure 2 and table 1). Although the strong immunostaining was slightly higher in high-grade dysplasia and EA than in low-grade dysplasia, the difference did not reach the statistical significance. The data suggest that SODD may be a potential marker for dysplasia and EA.
SODD is involved in acid-induced decrease in cell apoptosis in EA cells.
Since acid reflux may play an important role in the progression from BE to dysplasia and to adenocarcinoma (Fitzgerald et al., 1996; Ouatu-Lascar et al., 1999) , we examined whether acid treatment affects levels of SODD protein. Acid treatment significantly increased SODD protein level in FLO cells (figure 3A & 3B) and mRNA levels in CP-A cells ( figure 3C ). In addition, acid treatment significantly increased the luciferase activity in FLO cells transfected with SODD reporter plasmid pGL3-SODDP ( figure 3D ). The data suggest that acid treatment may increase SODD promoter activity and protein expression in FLO EA cells and mRNA expression in CP-A cells. Moreover, acid treatment significantly decreased caspase 9 activity in FLO EA cells ( figure   3E ), a decrease which was blocked by knockdown of SODD ( figure 3F ). At the basal condition, SODD siRNA significantly increased caspase 9 activity by 32.5% (N=3, p<0.02). Furthermore, acid-induced decrease in cell apoptosis was reversed by knockdown of SODD ( figure 3G ). These This article has not been copyedited and formatted. The final version may differ from this version. 
NOX5-S may contribute to acid-induced SODD expression in FLO cells.
We have shown that NADPH oxidases may mediate acid-induced H 2 O 2 production in Barrett's mucosal biopsies (Fu et al., 2006) and that NADPH oxidase NOX5-S is the major isoform of NADPH oxidases in FLO EA cells (Hong et al., 2010a) . Therefore, we examined whether NOX5-S participates in acid-induced increase in SODD expression. Western Blot analysis and summarized data showed that knockdown of NOX5-S with its siRNA, which has been shown by us to effectively knock down NOX5-S expression (Fu et al., 2006) , significantly decreased SODD expression in response to acid treatment in FLO cells ( figure 3A & 3B) .
Knockdown of NOX5-S also significantly decreased SODD mRNA expression in CP-A cells ( figure 3C ) and remarkably inhibited acid-induced increase in luciferase activity in FLO cells transfected with SODD reporter plasmid pGL3-SODDP ( figure 3D ). These data suggest that acid-induced SODD expression may be mediated by activation of NOX5-S. To further confirm this result, we transfected NOX5-S expression plasmid into FLO EA cells, which has been shown by us to overexpress NOX5-S protein (Si et al., 2007) , and found that overexpression of NOX5-S significantly increased the protein expression of SODD ( figure 4A &4B) . Moreover, overexpression of NOX5-S dramatically increased the luciferase activity in FLO cells transfected with SODD reporter plasmid pGL3-SODDP ( figure 4C ) and significantly decreased caspase 9 activity ( figure 4D ) and cell apoptosis ( figure 4E ) at the basal condition in FLO EA cells. The data suggest that NOX5-S may be involved in SODD expression in FLO EA cells.
Role of NF-κB in acid-induced SODD expression
This article has not been copyedited and formatted. The final version may differ from this version. We have shown that NADPH oxidase NOX5-S mediates acid-induced cyclooxygenase-2 expression via activation of NF-κB in Barrett's esophageal adenocarcinoma cells (Si et al., 2007 ).
Next we examined whether NF-κB participates in acid-induced SODD expression in FLO cells.
We found that knockdown of p50 with its siRNA, which has been shown by us to effectively knock down p50 expression (Si et al., 2007) , significantly decreased acid-induced increase in SODD protein expression in FLO cells ( figure 5A & 5B) and in SODD mRNA expression in CP-A cells ( figure 5C ). In addition, knockdown of p50 significantly decreased NOX5-S-overexpression-or acid-induced increase in luciferase activity in FLO cells transfected with SODD reporter plasmid pGL3-SODDP ( figure 4C and 5D ). Moreover, overexpression of NF-κB p50 significantly increased the luciferase activity in FLO cells transfected with SODD reporter plasmid pGL3-SODDP ( figure 5E ) and remarkably decreased the cell apoptosis in FLO cells ( figure 5F ). The data suggest that NF-κB p50 may be involved in acid-induced increase in SODD expression.
We identified one possible NF-κB binding element, GGGACACCCT (positions -310 to -300), in the SODD promoter. To test whether NF-κB binds to SODD promoter, we did chromatin immunoprecipitation (ChIP) assay. Figure 6A showed that SODD genomic DNA was identifiable in the immunoprecipitate of FLO EA cell lysate with p50 antibody. The pair of primers used in the PCR targeted the -367 to +17 (position from ATG) region of the SODD promoter and covered the possible NF-κB-binding site as described above. The PCR products were sequenced and proved to be SODD genomic DNA. The data suggest that NF-κB may bind to the SODD promoter. A gel mobility shift assay was also done to confirm the above result. In This article has not been copyedited and formatted. The final version may differ from this version. the gel shift assay, we identified one prominent complex by using Hela nuclear extracts and IRdye 700-labelled SODD oligonucleotide, containing the NF-κB binding site GGGACACCCT ( figure 6B) . A high concentration of unlabeled SODD oligonucleotide significantly reduced the binding, whereas the mutant SODD oligonucleotide had less effect on the binding ( figure 6B ). In addition, one prominent complex was also identifiable with IRdye 700-labelled SODD oligonucleotide and recombinant p50 protein ( figure 6C ). The bands of these prominent complex were super-shifted with a p50 antibody ( figure 6C ). These data further suggest that NF-κB p50 may bind to the potential binding site GGGACACCCT.
Discussion
Gastroesophageal reflux disease (GERD) complicated by Barrett's esophagus (BE) is a major risk factor for EA (Lagergren et al., 1999) . However, mechanisms of the progression from BE (intestinal metaplasia) to EA are not fully understood. We have previously shown that acid, a major refluxate in patients with Barrett's esophagus, increases ROS production in Barrett's mucosal biopsies (Fu et al., 2006) . This increase is blocked by NADPH oxidase inhibitor apocynin, suggesting that NADPH oxidases may mediate acid induced-increase in H 2 O 2 production (Fu et al., 2006) . NADPH oxidase has seven isoforms NOX1-5, DUOX1 and DUOX2 (Suh et al., 1999; Banfi et al., 2000; Lambeth, 2004) , where NOX5 has five isoforms:
α, β, δ and γ, and NOX5-S (Banfi et al., 2000; Vignais, 2002) . NOX5 α, β, δ and γ have EF-hand motifs at its N-terminal (Banfi et al., 2000) , whereas NOX5-S does not (Cheng et al., 2001) . We have previously shown that acid-induced H 2 O 2 production is mediated by the NADPH oxidase
NOX5-S and that acid-induced NOX5-S expression depends on an increase in intracellular
This article has not been copyedited and formatted. The final version may differ from this version. (Fu et al., 2006) .
Overproduction of ROS derived from upregulation of NOX5-S increases cell proliferation and decreases apoptosis. However, the mechanism of acid-induced decrease in cell apoptosis is still not fully understood in EA cells.
In this study, we found that acid treatment remarkably increased SODD protein expression and promoter activity in FLO EA cells and SODD mRNA expression in CP-A cells, suggesting that acid treatment may upregulate SODD. Moreover, acid significantly decreased cell apoptosis, a decrease which was inhibited by knockdown of SODD, indicating that SODD may contribute to acid-induced decrease in cell apoptosis in FLO cells. It has been reported that pulsed acid treatment (pH 4) increased cell proliferation in mucosal tissues (Fitzgerald et al., 1996) . We also found that pulsed acid treatment with pH 4.0 increased cell proliferation in FLO cells. Therefore, we used pH 4 in FLO cells. CP-A cells are less resistant to in vitro acid treatment. In our preliminary studies, we found that pH 4 and 5 caused cell apoptosis in CP-A cells, whereas pH 6.5 increased cell proliferation as seen in FLO cells and in Barrett's mucosal tissues. To mimic the findings obtained in mucosal tissues which are much closer to the in vivo condition, we used pH 6.5 in CP-A cells.
SODD belongs to a family of anti-apoptotic proteins of the BAG family (Takayama et al., 1999) and contains a conserved region of approximately 45 amino acids near its C terminal end, the so-called BAG domain. Over-expression of SODD has been reported to suppress cell death in various cancer cell lines (Jiang et al., 1999; Ozawa et al., 2000) . SODD interacts with the ATPase domain of Hsc70/Hsp70 (Takayama et al., 1999) 
through its BAG domain and is associated with
This article has not been copyedited and formatted. The final version may differ from this version. the cytoplasmic domain of the tumor necrosis factor receptor 1 (TNFR1) and death receptor-3, another member of the TNFR superfamily. TNF treatment releases SODD from TNFR1, permitting the recruitment of proteins such as TNFR-associated death domain and TNFR-associated factor 2 to the active TNFR1 signaling complex (Jiang et al., 1999) . Under un-stimulated condition, SODD binds TNFR1 and prevents the ligand-independent oligomerization and spontaneous activation of TNFR1, thus inhibiting the cell apoptosis (Doong et al., 2002) .
We also found that SODD expression was significantly increased in EA cells and tissues.
By immunohistochemistry, strong SODD immunostaining was significantly higher in dysplasia and esophageal adenocarcinoma than in Barrett's metaplastic cells, suggesting that SODD might be a potential marker for dysplasia and EA. Although the strong immunostaining was slightly higher in high-grade dysplasia and EA than in low-grade dysplasia, the difference did not reach the statistical significance, which might be due to our small sample size.
Acid-induced increase in SODD expression may depend on activation of NOX5-S since 1) knockdown of NOX5-S blocked acid-induced upregulation of SODD protein and mRNA; 2) knockdown of NOX5-S remarkably inhibited acid-induced increase in luciferase activity in FLO cells transfected with SODD reporter plasmid pGL3-SODDP; and 3) overexpression of NOX5-S significantly increased SODD promoter activity.
We have previously shown that NF-κB plays an important role in acid-induced cyclooxygenase-2 expression in Barrett's esophageal adenocarcinoma cells (Si et al., 2007) and that acid treatment significantly decreased IκBα protein levels and increased luciferase activity that acid may activate NF-κB (Si et al., 2007) . In addition, knockdown of NOX5-S significantly decreased acid-induced increase in luciferase activity in cells transfected with pNFκB-Luc, suggesting that activation of NF-κB may depend on activation of NOX5-S (Hong et al., 2013) .
Therefore, we examined the role of NF-κB in acid-induced SODD expression.
NF-κB has two isoforms p50 and p52 (Karin et al., 2002) . P50 is involved in lymphoid organogenesis and inflammation, whereas p52 mainly contributes to lymphoid organogenesis (Shih et al., 2011) . Therefore, we focused on the role of p50 in acid-induced SODD expression.
We found that knockdown of p50 significantly decreased acid-induced increase in SODD protein expression in FLO cells and in SODD mRNA expression in CP-A cells. In addition, knockdown of p50 significantly decreased NOX5-S-overexpression-or acid-induced increase in luciferase activity in FLO cells transfected with SODD reporter plasmid pGL3-SODDP.
Moreover, overexpression of NF-κB p50 significantly increased SODD reporter activity and remarkably decreased the cell apoptosis in FLO cells. These data suggest that NF-κB1 p50 may be responsible for acid-induced SODD expression in EA cells.
One NF-κB binding element GGGACACCCT (positions -310 to -300) was identified in the SODD promoter. Our data indicate that NF-κB may bind to this binding element since 1) SODD genomic DNA was identifiable in the immunoprecipitate of EA cell lysate with p50 antibody; 2)
In the gel shift assay, IRdye 700-labelled SODD oligonucleotide containing the NF-κB binding had no effect on binding. These data suggest that NF-κB binds to the site GGGGACACCCT at the SODD promoter.
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